Page 4 - Best Rectal cancer doctors: TOP 113 doctors

49 years of experience specializing in virotherapy – Dr. Jaunalksne leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.

• Head of Clinical Immunology Center at a major university hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on cutting-edge immunological approaches

Dr. Alemdar specializes in medical oncology with a focus on personalized treatment plans for rectal cancer patients.

• Graduated from Kocaeli University Faculty of Medicine
• Specialized in Medical Oncology at Akdeniz University
• Extensive experience in hospitals across Turkey
• Currently practices at Medical Park Antalya Hospital Complex

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center with 36 years of experience focused on oncology and radiotherapy.

• Specializes in Medical Oncology & Radiotherapy
• Head of Gastrointestinal Cancer Center
• Board-certified in Oncology & Radiotherapy
• Member of Israel Society of Clinical Oncology
• Educated at Hebrew University and Hadassah University Hospital

Dr. Ercan Ozden trained at prestigious Istanbul University and specializes in medical oncology with a focus on rectal cancer.

• Completed medical oncology subspecialty at Kocaeli University
• Over a decade of internal medicine experience
• Practiced at multiple reputable hospitals in Turkey
• Graduated from Istanbul University's English Medical Program

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Joseba Rebollo Liceaga brings over 36 years of experience of oncology experience, specializing in rectal cancer at Quironsalud Torrevieja.

• Head of Oncology at Clínica San Miguel de Navarra for 36 years of experience
• Authored research on electrochemotherapy and multidisciplinary treatments
• Specialist in Medical Oncology from Clínica Universidad de Navarra
• Associate Physician at University of Navarra's Faculty of Medicine

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Kinas specializes in oncological and colorectal surgeries, with extensive experience in treating rectal cancer at Büyük Anadolu Hospitals.

• Skilled in both traditional and advanced surgical techniques
• Focuses on pancreatic, bile duct, and colon cancer surgeries
• Also experienced in bariatric metabolic and diabetes surgeries

15,000+ surgical procedures in – Dr. de Lacy specializes in minimally invasive techniques for rectal cancer at Hospital Quiron Barcelona.

• Performs over 1,000 minimally invasive surgeries annually
• Pioneer of TaTME technique for rectal cancer
• President of the Association of Surgeons-Endoscopists in Europe
• Lecturer on advanced laparoscopy techniques

Dr. Zalmanova specializes in radiotherapy for rectal cancer at Assuta Medical Center.

• Radiotherapist with a focus on rectal cancer treatment
• Works at Assuta Medical Center, a leading oncology facility
• Dedicated to personalized treatment plans for each patient

Honor graduate from Hacettepe University, specializing in nutrition for cancer patients and post-bariatric surgery care.

• Conducted research on the relationship between nutrition and chronic diseases
• Interned at top hospitals including Hacettepe University Oncology Hospital
• Completed specialized courses in bariatric nutrition and obesity
• Works with diverse patient groups including cancer and diabetes patients

He leads the Department of Surgery at Hadassah Medical Center, focusing exclusively on colorectal cancer and skin malignancies.

• Specializes in treating colorectal cancer
• Heads the Department of Surgery at Hadassah Medical Center
• Focuses his clinical practice on colorectal and skin cancers

Dr. Beny leads the Gastrointestinal Malignant Service at Rambam Medical Center, focusing specifically on cancers of the digestive tract.

• Senior physician with over of experience in medical and radiation oncology
• Runs a dedicated gastro-intestinal oncology clinic for targeted care
• Board-certified in Israel with European Community medical qualifications
• Completed advanced training courses, including an ESTRO course in modern brachytherapy